These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 28887133)

  • 1. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
    Wong CY; Al-Salami H; Dass CR
    J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
    Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment.
    Mumuni MA; Kenechukwu FC; Ofokansi KC; Attama AA; Díaz DD
    Carbohydr Polym; 2020 Feb; 229():115506. PubMed ID: 31826394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of biodegradable polymeric systems for oral insulin delivery.
    Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
    Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the efficacy and safety of nanoparticle-based oral insulin delivery systems.
    Card JW; Magnuson BA
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G956-67. PubMed ID: 21921287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nanocomposite Vehicle Based on Metal-Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery.
    Zhou Y; Liu L; Cao Y; Yu S; He C; Chen X
    ACS Appl Mater Interfaces; 2020 May; 12(20):22581-22592. PubMed ID: 32340452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Characterization of Hypoglycemic Nanoparticles for Oral Insulin Delivery.
    Zhang L; Zhang YX; Qiu JN; Li J; Chen W; Guan YQ
    Biomacromolecules; 2017 Dec; 18(12):4281-4291. PubMed ID: 29059517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.
    Bhumkar DR; Joshi HM; Sastry M; Pokharkar VB
    Pharm Res; 2007 Aug; 24(8):1415-26. PubMed ID: 17380266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Feb; 537(1-2):223-244. PubMed ID: 29288095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strategies to oral delivery of insulin: Current progress of nanocarriers for diabetes management.
    Abdel-Moneim A; Ramadan H
    Drug Dev Res; 2022 Apr; 83(2):301-316. PubMed ID: 34859477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.
    Socha M; Sapin A; Damgé C; Maincent P
    Drug Deliv; 2009 Nov; 16(8):430-6. PubMed ID: 19839787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
    Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
    Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.